Cargando…

COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation

We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexamethasone and tocilizumab. One week after discharge, he developed abnormal be...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Makoto, Kouda, Kento, Mizoguchi, Tomotaka, Yokota, Yuki, Hayashi, Kentaro, Gon, Yasuhiro, Nakajima, Hideto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267028/
https://www.ncbi.nlm.nih.gov/pubmed/34229469
http://dx.doi.org/10.1177/23247096211029787
_version_ 1783720053696364544
author Hara, Makoto
Kouda, Kento
Mizoguchi, Tomotaka
Yokota, Yuki
Hayashi, Kentaro
Gon, Yasuhiro
Nakajima, Hideto
author_facet Hara, Makoto
Kouda, Kento
Mizoguchi, Tomotaka
Yokota, Yuki
Hayashi, Kentaro
Gon, Yasuhiro
Nakajima, Hideto
author_sort Hara, Makoto
collection PubMed
description We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexamethasone and tocilizumab. One week after discharge, he developed abnormal behavior and delirium without fever and respiratory symptoms. Brain magnetic resonance imaging showed no abnormalities. Cerebrospinal fluid showed pleocytosis and elevated protein concentrations and was negative for severe acute respiratory syndrome-coronavirus-2 RNA. No anti-neuronal autoantibodies against intracellular and neuronal surface proteins were detected. The cerebrospinal fluid inflammatory changes compatible with post-infectious encephalitis, and the patient recovered with intravenous methylprednisolone and intravenous immunoglobulin therapy. Delirium could be an initial symptom of post-infectious encephalitis in older adults with COVID-19, and these patients may require immunosuppressive therapy.
format Online
Article
Text
id pubmed-8267028
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-82670282021-07-19 COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation Hara, Makoto Kouda, Kento Mizoguchi, Tomotaka Yokota, Yuki Hayashi, Kentaro Gon, Yasuhiro Nakajima, Hideto J Investig Med High Impact Case Rep Case Report We report the case of a 65-year-old man with COVID-19 (coronavirus disease-2019) post-infectious encephalitis who presented with delirium as an initial manifestation. He had severe COVID-19 pneumonia and recovered with dexamethasone and tocilizumab. One week after discharge, he developed abnormal behavior and delirium without fever and respiratory symptoms. Brain magnetic resonance imaging showed no abnormalities. Cerebrospinal fluid showed pleocytosis and elevated protein concentrations and was negative for severe acute respiratory syndrome-coronavirus-2 RNA. No anti-neuronal autoantibodies against intracellular and neuronal surface proteins were detected. The cerebrospinal fluid inflammatory changes compatible with post-infectious encephalitis, and the patient recovered with intravenous methylprednisolone and intravenous immunoglobulin therapy. Delirium could be an initial symptom of post-infectious encephalitis in older adults with COVID-19, and these patients may require immunosuppressive therapy. SAGE Publications 2021-07-07 /pmc/articles/PMC8267028/ /pubmed/34229469 http://dx.doi.org/10.1177/23247096211029787 Text en © 2021 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Hara, Makoto
Kouda, Kento
Mizoguchi, Tomotaka
Yokota, Yuki
Hayashi, Kentaro
Gon, Yasuhiro
Nakajima, Hideto
COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation
title COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation
title_full COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation
title_fullStr COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation
title_full_unstemmed COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation
title_short COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation
title_sort covid-19 post-infectious encephalitis presenting with delirium as an initial manifestation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267028/
https://www.ncbi.nlm.nih.gov/pubmed/34229469
http://dx.doi.org/10.1177/23247096211029787
work_keys_str_mv AT haramakoto covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation
AT koudakento covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation
AT mizoguchitomotaka covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation
AT yokotayuki covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation
AT hayashikentaro covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation
AT gonyasuhiro covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation
AT nakajimahideto covid19postinfectiousencephalitispresentingwithdeliriumasaninitialmanifestation